Hi SoT, I find myself in partial agreement only with your thoughts of D-I-Y philosophy. Whilst attractive for full revenues staying inhouse, we have to get it/them fully approved first, and there-in can lie problems. We would not be the first company with a life changing drug to suffer at the hands of FDA for not holding hands with a BP company! BP can and does gr’eze’ the wheel's thru the system and/or obfuscate the process! They also provide a ready made network for market distribution if/when approved. Pros and cons either way imho.
PYC Price at posting:
8.3¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)